Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
4.675
-0.065 (-1.37%)
Mar 20, 2026, 2:51 PM EDT - Market open
Niagen Bioscience Employees
Niagen Bioscience had 117 employees as of December 31, 2025. The number of employees increased by 13 or 12.50% compared to the previous year.
Employees
117
Change (1Y)
13
Growth (1Y)
12.50%
Revenue / Employee
$1,106,179
Profits / Employee
$148,564
Market Cap
374.38M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 117 | 13 | 12.50% | 117 | 0 |
| Dec 31, 2024 | 104 | -2 | -1.89% | 104 | 0 |
| Dec 31, 2023 | 106 | -7 | -6.19% | 106 | 0 |
| Dec 31, 2022 | 113 | -2 | -1.74% | 113 | 0 |
| Dec 31, 2021 | 115 | 5 | 4.55% | 115 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 2, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 650 |
| X4 Pharmaceuticals | 143 |
| Kyverna Therapeutics | 129 |
| Enanta Pharmaceuticals | 120 |
| Lineage Cell Therapeutics | 77 |
| PureTech Health | 56 |
| Anavex Life Sciences | 34 |
| DiaMedica Therapeutics | 28 |
NAGE News
- 1 day ago - Niagen Bioscience Increases Share Repurchase Program to $20 Million - Business Wire
- 2 days ago - Niagen Bioscience to Present at the 38th Annual ROTH Conference - Business Wire
- 3 days ago - Niagen Bioscience Surpasses 300 External Research Agreements from Leading Global Institutions on Niagen®, Contributing to 45 Published Clinical Studies - Business Wire
- 10 days ago - Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen NanoCloud™, From Tru Niagen Powered by Patented Niagen® - Business Wire
- 15 days ago - Niagen Bioscience, Inc. (NAGE) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 15 days ago - Niagen Bioscience Reports 30% Year-Over-Year Net Sales Increase to $129.4 million, 103% Net Income Increase to $17.4 million or $0.22 Basic EPS in 2025 - Business Wire
- 22 days ago - Niagen Bioscience to Streamline and Focus its Operations with the Sale of ChromaDex Reference Standards Business to LGC in All-Cash Transaction - Business Wire
- 23 days ago - Niagen Bioscience Secures New U.S. Patent Covering Intravenous and Injection Formulations and Methods of Use for Nicotinamide Riboside (NR), Niagen® - Business Wire